Marbofloxacin
CAS Number: 115550-35-1 Therapeutic Category: Anti-Bacterial Mode of Action: Inhibits pyruvate–ferredoxin oxidoreductase (PFOR) enzyme-dependent electron transfer in anaerobic pathogens Primary Use: Treatment of Giardia, Cryptosporidium, and helminths (off-label in vet use) Spectrum of Activity: Protozoa, helminths, anaerobic bacteria Target Species: Pets (dogs and cats), equine, swine, chicken, field animals, milking animals Status: Commercial Monograph: IP, […]
